Skip to content

Company information lookup


A pooled development fund that invests in pharmaceutical businesses developing new products involving the delivery of pharmaceuticals via the skin.

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Warrants & Structured Products

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
ACR 1.530 -5.26% 1.515 1.540 1.590 1.590 1.500 796,735


Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code ACR
Official Listing Date 29 September, 2004
GICS Industry Group Pharmaceuticals & Biotechnology
Exempt Foreign? No
Internet Address
Registered Office Address 103-113 Stanley Street, WEST MELBOURNE, VIC, AUSTRALIA, 3003
Head Office Telephone (03) 8379 0100
Head Office Fax (03) 8379 0101
Share Registry Telephone 1300 554 474
Directors / Senior Management
Mr Ross Dobinson (Chairman)
Mr Ross Barrow (Non Exec. Director)
Mr Timothy Oldham (Non Exec. Director)
Mr Bruce Parncutt (Non Exec. Director)
Ms Sharon Papworth (CFO)
Company Secretary Ms Sharon Papworth
Principal Activities A pooled development fund that invests in pharmaceutical businesses developing new products involving the delivery of pharmaceuticals via the skin.

ACRUX LIMITED announcements

How are company announcements published on

Date Price
Headline Pages PDF
24/09/2014   Company Secretary Change 1 PDF
18/09/2014 asterix Response to ASX Price Query 4 PDF
18/09/2014   FDA Advisory Committee Meeting on TRT 2 PDF
18/09/2014 asterix Trading Halt 1 PDF
05/09/2014 asterix S&P DJ Indices Announces September Quarterly Rebalance 4 PDF
21/08/2014 asterix Hexima Collaboration Update 1 PDF
21/08/2014   Dividend, June 2014 Results and Company Update 5 PDF
21/08/2014 asterix Appendix 4E and Financial Report to 30 June 2014 64 PDF
20/08/2014 asterix Marketing Approval Granted for Estradiol Spray South Africa 1 PDF
25/07/2014 asterix Axiron Net Sales for the Quarter to 30 June 2014 1 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
01 Oct 2014 1.615 4.87% 1.645 1.550 1,736,830
30 Sep 2014 1.540 7.32% 1.560 1.445 1,339,844
29 Sep 2014 1.435 1.41% 1.480 1.435 720,468
26 Sep 2014 1.415 2.17% 1.430 1.335 764,148
25 Sep 2014 1.385 6.13% 1.410 1.310 1,474,790

* Volume of shares shown represents only those shares traded on ASX.

ACRUX LIMITED price history chart

* More charting options are available.


How are dividends released on

Code Div Amount Ex Div Date Record Date Date Payable % Franked Type Further Information
ACR 8c 03/09/2013 09/09/2013 23/09/2013 0% Final UNFRANKED NIL CFI
ACR 12c 25/02/2014 03/03/2014 20/03/2014 0% Interim UNFRANKED NIL CFI SPECIAL
ACR 8c 04/09/2014 08/09/2014 22/09/2014 100% Final 8C FRANKED @ 30%

Exchange Traded Options

No Exchange Traded Options are available over the security ACR

Warrants & Structured Products

Warrants & Structured Products are available over the security ACR. Click here to view the current warrant issue details.